- Home
- IDYA vs PACS Comparison
IDYA vs PACS Comparison
Compare IDYA & PACS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- PACS
- Stock Information
- Founded
- IDYA 2015
- PACS 2013
- Country
- IDYA United States
- PACS United States
- Employees
- IDYA N/A
- PACS N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- PACS
- Sector
- IDYA Health Care
- PACS
- Exchange
- IDYA Nasdaq
- PACS Nasdaq
- Market Cap
- IDYA 2.2B
- PACS 2.1B
- IPO Year
- IDYA 2019
- PACS 2024
- Fundamental
- Price
- IDYA $22.18
- PACS $13.81
- Analyst Decision
- IDYA Strong Buy
- PACS Strong Buy
- Analyst Count
- IDYA 13
- PACS 9
- Target Price
- IDYA $53.67
- PACS $33.22
- AVG Volume (30 Days)
- IDYA 890.0K
- PACS 602.3K
- Earning Date
- IDYA 02-18-2025
- PACS 02-16-2025
- Dividend Yield
- IDYA N/A
- PACS N/A
- EPS Growth
- IDYA N/A
- PACS 82.79
- EPS
- IDYA N/A
- PACS 0.68
- Revenue
- IDYA $3,922,000.00
- PACS $3,558,953,000.00
- Revenue This Year
- IDYA N/A
- PACS $29.04
- Revenue Next Year
- IDYA $251.89
- PACS $18.31
- P/E Ratio
- IDYA N/A
- PACS $20.30
- Revenue Growth
- IDYA N/A
- PACS 205.08
- 52 Week Low
- IDYA $22.10
- PACS $12.54
- 52 Week High
- IDYA $47.74
- PACS $43.92
- Technical
- Relative Strength Index (RSI)
- IDYA 31.90
- PACS N/A
- Support Level
- IDYA $22.17
- PACS N/A
- Resistance Level
- IDYA $24.06
- PACS N/A
- Average True Range (ATR)
- IDYA 1.06
- PACS 0.00
- MACD
- IDYA -0.22
- PACS 0.00
- Stochastic Oscillator
- IDYA 1.84
- PACS 0.00
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.
About PACS PACS Group Inc. Common Stock
PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.